Netherlands· NL-6865a770426f
BCG-medac, poeder en oplosmiddel voor suspensie voor intravesicaal gebruik
A bcg-impfstoff product containing levende, gevriesdroogde kiemen van de calmette-guerin stam, registered in Netherlands by Medac Gesellschaft für klinische Spezialpräparate mbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Bcg-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC L03AX03 (bcg-impfstoff), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Bcg-impfstoff · ATC L03AX03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LEVENDE, GEVRIESDROOGDE KIEMEN VAN DE CALMETTE-GUERIN STAM
- Manufacturer
- Medac Gesellschaft für klinische Spezialpräparate mbH
- Country
- Netherlands (NL)
- ATC code
- L03AX03
- ATC class
- BCG-Impfstoff
- Defined daily dose
- 0.033 Darreichungsform, intravesikal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id26876
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bcg-impfstoff in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainONCOTICE 2-8 X 10(8) UFC POLVO PARA SUSPENSION INTRAVESICALMerck Sharp & Dohme De Espana S.A.
- SwitzerlandBCG-medac
- FinlandBcg VaccineChiron Vaccines Limited
- PolandBCG Szczepionka AJVaccinesAJ Vaccines A/S
- United KingdomBCG-medac 1,600million units powder and solvent for suspension for instillation vials with conical adapter and catheterImported (Germany)
- CanadaVERITY-BCGVERITY PHARMACEUTICALS INC.
- SwedenOncoTICE 12,5 mg Pulver till lösning för intravesikal användningMerck Sharp & Dohme BV
- GermanySanukehlklebs D6 Sanum-KehlbeckSanum-Kehlbeck Gmbh & Co.Kg
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Bcg
- Bulgaria · Бцж Ваксина, Калгевакс
- Slovenia · Bcg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e10344f4-d3f4-47e7-8789-f8d758de8ac2 GET /v1/drugs/e10344f4-d3f4-47e7-8789-f8d758de8ac2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor blaasspoeling",
"route": "Intravesicaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26876_smpc.pdf",
"strength": null,
"atc_label": "Bcg Vaccine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26876",
"excipients": [
"GLUCOSE 0-WATER",
"NATRIUMCHLORIDE",
"POLYGELINE",
"POLYSORBAAT 80 (E 433)",
"WATER, GEZUIVERD"
],
"substances": [
"LEVENDE, GEVRIESDROOGDE KIEMEN VAN DE CALMETTE-GUERIN STAM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26876.pdf",
"authorised_at": "2002/06/28",
"procedure_number": "DE/H/0212/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "26876",
"additional_monitoring": "N"
}See everything about bcg-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.